After already halving its workforce twice since 2022, Sensei Therapeutics is forging ahead with another deep round of cuts. The biotech on Friday said 65% of its staffers are set to leave the company.

Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning of imminent layoffs as the company mulls its options. Two weeks ago, the biotech reported phase 1/2 data for its ...

BOSTON - Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) announced Thursday it will discontinue development of its cancer drug solnerstotug and initiate a strategic review to maximize shareholder value.

BOSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Los Angeles-based Sensei was ...

The Yari in Ghost of Yotei is a weapon that you can unlock as you progress through the game and complete a series of tasks. It's a versatile spear that provides you with much longer reach than your ...

One of the world’s richest men is expanding his investments in Central Texas. Sensei Farms, the agriculture company backed by Oracle Corp. co-founder, Chairman and Chief Technology Officer Larry ...

Travelers are chasing more than rest; they want lasting vitality. Alexandra Walterspiel is betting that the future of luxury lies in wellness, and her approach at Sensei hints at where high-end ...

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics ...